European Medical Journal Presents: EMJ Neurology 6.1 - European Medical Journal

European Medical Journal Presents: EMJ Neurology 6.1

1 Mins
Neurology

London, United Kingdom, August 7, 2018

The publication of EMJ Neurology 6.1 is now available, presenting a full review of the European Academy of Neurology (EAN) 2018 Congress, this year held in Lisbon, Portugal.

As always, the latest eJournal from the European Medical Journal features an assortment of peer-reviewed articles that are sure to whet the appetite of every neurology specialist, with topics ranging from Behçet’s disease to a palliative approach to amyotrophic lateral sclerosis care, in addition to key insights from members of the EMJ Neurology Editorial Board and an array of specially selected abstracts presented at EAN 2018.

While the EAN Congress may only be in its fourth year, Prof Dr Lászlo Vécsei, EMJ Neurology Editor-in-Chief, states: “The event does an impressive job of bringing together all the various aspects of neurological diseases as well as facilitating the discussion of clinical practice and research”.  With the over-arching theme of neurogenetics at EAN 2018, this year’s eJournal presents key research, discussion points, and future directions for neurological advancement within its extensive Congress Review, detailing the approval of the first drug to treat secondary multiple sclerosis, new treatment guidelines, an investigation into consciousness after stroke, and much more.

EMJ Neurology 6.1 showcases fascinating content that will spark countless hours of intense debate, no doubt leading to further developments and breakthroughs within neurology.

If you would like more information about this publication, please call Stacey Rivers at +44 (0) 1245 334450, or email [email protected].

 

Notes to Editors

About EMJ

Renowned for being the only medical journal to review the biggest European congresses, six weeks after each event is held, the European Medical Journal, is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in the field.

Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest from the field within our medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research and review papers from a variety of topics, alongside unique features and interviews. If you’re interested in receiving quarterly newsletters, and the latest publications straight to your inbox, please do subscribe for free: https://www.emjreviews.com/mailing-list/.

 

 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given